DB
CVAC

Dmitry Balyasny’s CureVac CVAC Stock Holding History

Dmitry Balyasny’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,317
Closed -$111K – 2712
2023
Q4 		$111K Sell
26,317
-47,828
-65% -$259K ﹤0.01% 2375
2023
Q3 		$506K Sell
74,145
-550,733
-88% -$4.86M ﹤0.01% 1751
2023
Q2 		$6.51M Sell
624,878
-490,885
-44% -$4.39M 0.01% 962
2023
Q1 		$7.78M Sell
1,115,763
-284,532
-20% -$2.48M 0.02% 880
2022
Q4 		$8.44M Buy
+1,400,295
New +$10.3M 0.02% 804
2022
Q2 		– Sell
-187,858
Closed -$3.68M – 2826
2022
Q1 		$3.68M Buy
+187,858
New +$3.75M 0.01% 1084

Other funds holding CVAC

Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Dmitry Balyasny's CVAC Position: Q1 2024 in Review

Dmitry Balyasny sold out of CureVac (CVAC) in Q1 2024, closing a stake of 26,317 shares — an estimated $111K sold.

Dmitry Balyasny first reported a position in CVAC in Q1 2022 and held it in 6 quarters. The position peaked at $8.44M in Q4 2022. 90 funds tracked by Wall St. Rank hold CVAC as of Q1 2024.

  • Dmitry Balyasny reported no remaining CureVac position as of Q1 2024 after selling out during the quarter.
  • Dmitry Balyasny sold 26,317 CureVac shares in Q1 2024, an estimated $111K.
  • Dmitry Balyasny first reported a position in CureVac in Q1 2022 and held it in 6 quarters.
  • Dmitry Balyasny's CureVac position peaked at $8.44M in Q4 2022.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.